Basics Alto Neuroscience Inc. IPO Date: February 2, 2024 Sector: Healthcare Industry: Biotech Market Cap: $61.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 4.03% Avg Daily Range (30 D): $0.08 | 3.44% Avg Daily Range (90 D): $0.11 | 4.36% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 119 Avg Trade Size (Sh.) (90 D): 129 Institutional Trades Total Inst.Trades: 68 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.39M Avg Closing Trade (30 D): $3.88M Avg Closing Trade (90 D): $2.32M Avg Closing Volume: 348.46K     News Jun 3, 2025 @ 6:48 PM Alto Neuroscience Adds 'Intriguing' Depression Ass... Source: Vandana Singh Oct 30, 2024 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Apr 23, 2024 @ 6:55 PM Treatment Patch For Schizophrenia: Newly Listed Al... Source: Vandana Singh Apr 9, 2024 @ 1:37 PM Alto Neuroscience (ANRO): Strong Industry, Solid E... Source: Zacks Equity Research Feb 9, 2024 @ 9:29 PM Wall Street hungry for IPO of Mexican supermarket ... Source: MarketWatch Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.34 $-.56 $-.56 Diluted EPS $-2.34 $-.56 $-.56 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -63.18M $ -15.17M $ -15.2M Operating Income / Loss $ -69.9M $ -15.68M $ -17M Cost of Revenue $ $ $ Net Cash Flow $ -44.64M $ -7.48M $ -13.47M PE Ratio